How One Immunology Brand Rewrote Its Launch Strategy in 5 Days
An immunology manufacturer preparing for launch came to us with a clear, well-researched strategy. But with growing pressure from competitors and tightening access conditions, they knew they couldn’t rely on internal alignment alone.
We deployed MAVA® to engage a panel of real-world payers within five days. Then, we ran those insights through Elasticity™ to model pricing scenarios and pressure-test their assumptions against validated product attributes.
The result? A complete shift in their launch approach.
They restructured their contracting model, reprioritized evidence needs, and avoided a rebate framework that would have eroded long-term value. That fast, their entire strategy got sharper.
As their Senior Director of Medical Payer Strategy put it:
“The information we were able to obtain from the payer panel was enterprise critical. The insights provided shifted the company’s strategic direction for launch readiness.”
The power of payer-driven insight is faster, deeper, and more actionable than traditional market research.
Want to see how MAVA + Elasticity™ can de-risk your next launch, or join our panel of 5,000+ decision-makers shaping the future of access? Let’s connect – email alexacasciano@emaxhealth.net.